Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness

Transcription

1 2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities Committee Member Employment Consultant Speaker s Bureau Ownership/ Thomas Bashore Theodore A. Bass Ralph G. Brindis John Brush Duke University ; Clinical Chief, Division of Florida Shands Jacksonville Center Professor of ; Chief Division California, San Francisco Clinical Eastern Virginia Medical School; Sentara Specialists, Sentara Healthcare Daiichi Sankyo- Lilly AHA* ABIM DAPT Trial State of California Health Department STEMI-PCI Work Group State of California Office of Statement Health Planning and Development C-PORT Elective RCT United Healthcare Scientific Advisory Board Healthcare Incentives Improvement Institute James A. Burke Lehigh Valley

2 Greg J. Dehmer Heart Network Associate Chief of TexasA&M College of, Scott & White Clinic Division ; Director of FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee American Medical Foundation for Peer Review C-PORT Elective Trial * Direct Flow Medical, IP005Percutaneous Valve Study Accreditation for Excellence* Yuri Deychak John Harold Johns Hopkins Community Physicians Heartcare Cardiologist Cedars-Sinai Heart Institute Attending Physician; Cedars-Sinai Medical Center and David Geffen School of at UCLA Clinical Champion PCI SI Champion Platform SI PLATO SI TIMI 50 SI TRACER SI SATURN SI IMPROVE IT SI TRITON TIMI 38 SI ABIM* AHA* Hani Jneid Baylor College of

3 James Jollis Joel Landzberg Glenn Levine James B. McClurken and the MEDVAMC of Duke University of Hackensack University Medical Center Clinical of Baylor College of Temple University Hospital Cardiothoracic Surgery Medtronic Foundation Sanofi-Aventis Boehringer Ingelheim, RELY, RELYABLE studies PI Roche, DALoutcomes study PI NIH Bridges Study PI Patient nonresponsive after noncardiac surgery, 2010* temporary pacing wire CABG graft laceration, 2009 retained foreign body, reoperative cardiac surgery, 2008 small bowel injury after reoperative

4 John C. Messenger Colorado Director, Cardiac Catheterization Lab; of Issam D. Moussa Mayo Clinic, Florida Professor and Chair, Division of Diseases J. Brent Muhlestein Intermountain Richard M. Pomeranz St. Agnes Hospital Chairman, CABG, 2007 heparine induced thrombocytope nia after CABG, 2006 Medtronic* Plaintiff, Medical malpractice suit interventional procedure performed below standard of care, 2009* Bristol Myers Squibb Daiichi-Sankyo Forest Gilead Eli Lilly Merck Sanofi-Aventis Glaxo St. Agnes Hospital* sudden cardiac death, 2011 mitral valve prolapsed, 2011 cardiac care of of patient,

5 Timothy Sanborn Chittur Sivaram Christopher J. White Northshore University Healthsystem Head, Division of Oklahoma and Associate Dean Ochsner Clinic Foundation Chairman, 2010 Medtronic Baxter Boston Scientific Corporation* Neovasc* St. Jude Accreditation for Excellence NCDR-CARE Registry* Eric S. Williams Indiana University School of Krannert Institute of and Associate Dean This table represents all healthcare relationships of committee members with industry and other entities that were reported by authors, including those not deemed to be relevant to this document, at the time this document was under development. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% of the voting stock or share of the business entity, or ownership of $10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Please refer to for definitions of disclosure categories or additional information about the ACCF Disclosure Policy for Writing Committees. * No financial benefit Indicates significant relationship ABIM indicates American Board of Internal ; ACCF, American College of Foundation; AHA, American Heart Association; DSMB, Data Safety Monitoring Board; FDA, Food and Drug Administration; NCDR, National Data Registry;